Positivity rate of interferon-Î³ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan.

Igari, Hidetoshi; Akutsu, Naotake; Ishikawa, Satoru; Aoyama, Hiromichi; Otsuki, Kazunori; Hasegawa, Masayuki; Maruyama, Michihiro; Tsuyuzaki, Mizue; Suzuki, Kiminori; Saigo, Kenichi

Igari, Hidetoshi; Akutsu, Naotake; Ishikawa, Satoru; Aoyama, Hiromichi; Otsuki, Kazunori; Hasegawa, Masayuki; Maruyama, Michihiro; Tsuyuzaki, Mizue; Suzuki, Kiminori; Saigo, Kenichi.

Afiliação

Igari H; Division of Infection Control, Chiba University Hospital, Chiba, Japan. Electronic address: igari_h@chiba-u.jp.
Akutsu N; Department of Surgery, National Hospital Organization Chiba-East Hospital, 673 Nitona-cho Chuo-ku, Chiba, 260-8712, Japan. Electronic address: nakutsu@cehpnet.com.
Ishikawa S; Department of Respiratory Medicine, National Hospital Organization Chiba-East Hospital, 673 Nitona-cho Chuo-ku, Chiba, 260-8712, Japan. Electronic address: tetsu.is@gmail.com.
Aoyama H; Department of Surgery, National Hospital Organization Chiba-East Hospital, 673 Nitona-cho Chuo-ku, Chiba, 260-8712, Japan. Electronic address: a.hiromichi@cehpnet.com.
Otsuki K; Department of Surgery, National Hospital Organization Chiba-East Hospital, 673 Nitona-cho Chuo-ku, Chiba, 260-8712, Japan. Electronic address: otsuki@cehpnet.com.
Hasegawa M; Department of Surgery, National Hospital Organization Chiba-East Hospital, 673 Nitona-cho Chuo-ku, Chiba, 260-8712, Japan. Electronic address: Clinic1159@yahoo.co.jp.
Maruyama M; Department of Surgery, National Hospital Organization Chiba-East Hospital, 673 Nitona-cho Chuo-ku, Chiba, 260-8712, Japan. Electronic address: maruyama@cehpnet.com.
Tsuyuzaki M; Chiba Foundation for Health Promotion and Disease Prevention, 32-14 Shin-Minato Mihama-ku, Chiba, 261-0002, Japan. Electronic address: mi-tsuyuzaki@kenko-chiba.or.jp.
Suzuki K; Chiba Foundation for Health Promotion and Disease Prevention, 32-14 Shin-Minato Mihama-ku, Chiba, 261-0002, Japan. Electronic address: kimi.suzuki@nifty.com.
Saigo K; Department of Surgery, National Hospital Organization Chiba-East Hospital, 673 Nitona-cho Chuo-ku, Chiba, 260-8712, Japan. Electronic address: k_saigo@cehpnet.com.

J Infect Chemother ; 25(7): 537-542, 2019 Jul.

Article em En | MEDLINE | ID: mdl-30905632

Assuntos

Testes de Liberação de Interferon-gama/estatística & dados numéricos; Transplante de Rim/efeitos adversos; Tuberculose Latente/epidemiologia; Transplantados/estatística & dados numéricos; Adulto; Idoso; Antígenos de Bactérias/imunologia; Estudos Transversais; Feminino; Rejeição de Enxerto/imunologia; Rejeição de Enxerto/prevenção & controle; Humanos; Hospedeiro Imunocomprometido; Imunossupressores/administração & dosagem; Imunossupressores/efeitos adversos; Japão/epidemiologia; Tuberculose Latente/diagnóstico; Tuberculose Latente/microbiologia; Masculino; Pessoa de Meia-Idade; Mycobacterium tuberculosis/imunologia; Mycobacterium tuberculosis/isolamento & purificação; Prevalência; Adulto Jovem

Palavras-chave

Latent tuberculosis infection; Lymphocyte subsets; QuantiFERON-TB gold plus; Renal transplantation; T-Spot.TB

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Tuberculose Latente / Testes de Liberação de Interferon-gama / Transplantados Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google